NYKODE THERAPEUTICS ASA financial statements, including revenue, expenses, profit, and loss
The total revenue of NYKDO for the last quarter is 8.70 M NOK, and it's 63.35% lower compared to the previous quarter. The net income of Q1 24 is -157.23 M NOK.